These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage. Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870 [TBL] [Abstract][Full Text] [Related]
3. Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan. Lamming DW; Mihaylova MM; Katajisto P; Baar EL; Yilmaz OH; Hutchins A; Gultekin Y; Gaither R; Sabatini DM Aging Cell; 2014 Oct; 13(5):911-7. PubMed ID: 25059582 [TBL] [Abstract][Full Text] [Related]
4. Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex. Carson RP; Fu C; Winzenburger P; Ess KC Hum Mol Genet; 2013 Jan; 22(1):140-52. PubMed ID: 23049074 [TBL] [Abstract][Full Text] [Related]
5. Rictor/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure. Chen Z; Kang X; Wang L; Dong H; Wang C; Xiong Z; Zhao W; Jia C; Lin J; Zhang W; Yuan W; Zhong M; Du H; Bai X J Biol Chem; 2015 Mar; 290(10):6387-96. PubMed ID: 25564616 [TBL] [Abstract][Full Text] [Related]
6. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
7. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism. Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304 [TBL] [Abstract][Full Text] [Related]
8. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition. Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307 [TBL] [Abstract][Full Text] [Related]
9. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Zhang C; Wendel AA; Keogh MR; Harris TE; Chen J; Coleman RA Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1667-72. PubMed ID: 22307628 [TBL] [Abstract][Full Text] [Related]
11. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609 [TBL] [Abstract][Full Text] [Related]
12. Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin. Zou Z; Chen J; Yang J; Bai X Curr Cancer Drug Targets; 2016; 16(4):288-304. PubMed ID: 26563881 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation. Walker NM; Belloli EA; Stuckey L; Chan KM; Lin J; Lynch W; Chang A; Mazzoni SM; Fingar DC; Lama VN J Biol Chem; 2016 Mar; 291(12):6262-71. PubMed ID: 26755732 [TBL] [Abstract][Full Text] [Related]
14. Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling. Zhang D; Tong X; Arthurs B; Guha A; Rui L; Kamath A; Inoki K; Yin L J Biol Chem; 2014 Sep; 289(37):25925-35. PubMed ID: 25063808 [TBL] [Abstract][Full Text] [Related]
15. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes. Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674 [TBL] [Abstract][Full Text] [Related]
16. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma. Zhang X; Wang X; Xu T; Zhong S; Shen Z Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752 [TBL] [Abstract][Full Text] [Related]
17. mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity. Mizunuma M; Neumann-Haefelin E; Moroz N; Li Y; Blackwell TK Aging Cell; 2014 Oct; 13(5):869-78. PubMed ID: 25040785 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness. Artinian N; Cloninger C; Holmes B; Benavides-Serrato A; Bashir T; Gera J J Biol Chem; 2015 Aug; 290(32):19387-401. PubMed ID: 25998128 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition. Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229 [TBL] [Abstract][Full Text] [Related]